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Abstract
Background: Currently, there is a lack of vital information in the genetic makeup of Cryptosporidium especially in
developing countries. The present study aimed at determining the genotypes and subgenotypes of Cryptosporidium in
hospitalized Malaysian human immunodeficiency virus (HIV) positive patients.
Methodology/Principal Findings: In this study, 346 faecal samples collected from Malaysian HIV positive patients were
genetically analysed via PCR targeting the 60 kDa glycoprotein (gp60) gene. Eighteen (5.2% of 346) isolates were
determined as Cryptosporidium positive with 72.2% (of 18) identified as Cryptosporidium parvum whilst 27.7% as
Cryptosporidium hominis. Further gp60 analysis revealed C. parvum belonging to subgenotypes IIaA13G1R1 (2 isolates),
IIaA13G2R1 (2 isolates), IIaA14G2R1 (3 isolates), IIaA15G2R1 (5 isolates) and IIdA15G1R1 (1 isolate). C. hominis was
represented by subgenotypes IaA14R1 (2 isolates), IaA18R1 (1 isolate) and IbA10G2R2 (2 isolates).
Conclusions/Significance: These findings highlighted the presence of high diversity of Cryptosporidium subgenotypes
among Malaysian HIV infected individuals. The predominance of the C. parvum subgenotypes signified the possibility of
zoonotic as well as anthroponotic transmissions of cryptosporidiosis in HIV infected individuals.
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Introduction
The world is currently plagued with a global pandemic of
human immunodeficiency virus (HIV) infection. From its
discovery in 1981 to 2010, acquired immunodeficiency syndrome
(AIDS) has killed more than 34 million people worldwide. At
present, HIV infects about 0.5% of the world’s population [1].
HIV epidemic has expanded rapidly in Malaysia recording a
cumulative 105,471 HIV/AIDS cases in 2010 [2] since its first
case in 1987 [3]. HIV-infected individuals in developing countries
such as Malaysia are susceptible not only to opportunistic
infections but also predisposed to a myriad of enteric pathogens
which are endemic in the tropics [4]. Reports from many regions
of the world where HIV/AIDS is endemic have also acknowl-
edged that intestinal parasitism is widespread among these
populations [5].
One of the most common opportunistic intestinal parasite is
Cryptosporidium, a causative agent of cryptosporidiosis, a disease
which is commonly found in HIV-infected individual and is
currently listed as an AIDS defining illness by US Centers for
Disease Control and Prevention [6]. Globally the prevalence rate
of Cryptosporidium infection may account for 10 to 20% of the
cases of diarrhea in HIV-infected patients living in developed
countries and as much as 50% in under privileged countries
[7,8].
In Malaysia, the first cryptosporidiosis case was reported in
1984 [9]. Subsequently, there were five reports with prevalence
ranging from 3% to 23% among HIV-infected individuals
[4,10,11,12,13]. Two studies have noted the preponderance of
cryptosporidiosis among HIV patients with CD4 count less than
200 cell/mm
3 [4,12]. With impaired immunity especially in
patients with low immune level (CD4 counts ,200 cells/mm
3),
infections with intestinal parasites may result in diarrheal
symptoms [14]. Patients with CD4 count of .180 cells/mm
3
usually have self-limiting infections, whereas most patients with
counts ,140 cells/mm
3 develop severe and persistent infections
[15]. With the introduction of HAART which partially restores
the immune function, the incidence of opportunistic parasite
infection such as cryptosporidiosis has declined [16]. In Malaysia,
where infections with Cryptosporidium is widespread [17,18] and a
large proportion of HIV/AIDS patients are still not receiving
HAART, it is crucial that efforts are made to improve the
understanding of this opportunistic parasite in such patients [12],
in particular the genetic makeup of the parasite.
There is extensive genetic variation within the genus Cryptospo-
ridium. With at least 23 species of Cryptosporidium being considered
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human, mouse, cattle, pig, sheep, horse, goat, cat, dog, kangaroo,
chicken, turkey, fish, ferrets, lizard, monkey and deer [19,20].
With a few exceptions, most species and genotypes are host-
adapted in nature, having a narrow spectrum of natural host. Of
these 23 species, at least 7 have been found to infect HIV-infected
individuals (i.e. C. parvum, C. hominis, C. meleagridis, C. felis, C. muris,
C. canis and C. suis). The two species of greater significance in terms
of public health, however, are C. parvum and C. hominis. Given the
wide range of Cryptosporidium species, genotypes, and subgenotypes
infecting humans, and each may have different sources of
infection, transmission routes, and pathogenicity [21,22], identi-
fying the species and genotypes present in a population is crucial
for the identification of associated factors for transmission and
implementing control programs to limit exposure to infectious
oocysts.
Recent advances in the molecular characterization of Cryptospo-
ridium parasites have made it possible to differentiate Cryptosporidium
oocysts at species, genotypes and subgenotypes levels [23]. One
such tool is based on sequence analysis of the 60-kDa glycoprotein
gene (gp60), which allows the identification of many genotype
families and subgenotypes within each one [24]. Currently, the
gp60 gene is the most suitable and widely used genetic marker for
Cryptosporidium species infecting humans [25]. This locus is useful
for such studies because it contains multiple regions displaying
high mutation rates, including in particular, a ‘‘hyper-variable’’
microsatellite region [26]. Understanding the subgenotypes of C.
hominis and C. parvum may provide clues into the mechanisms of
infection of these organisms and lay scientific foundations for
effective therapeutic modalities [27,28].
Generally, there are eleven gp60 genotype families found in C.
parvum [25]. Genotype families IIa and IId are zoonotic as these
two have been identified infecting humans and animals. Genotype
families IIc and IId are also common and broadly distributed [25].
Presently, C. hominis comprises six defined gp60 genotype families
(Ia–Ig; excluding Ic, which is yet undefined) [25].
Studies of the gp60 gene have shown that certain genotype
families are geographically related, commonly found genotype
families Ia, Ib, Id and Ie which are commonly seen in Kenya,
Malawi, India, Peru and USA [24,26,29,30,31,32]. Although
cryptosporidiosis is prevalent in developing countries, genetic
characterization is lacking in Asia, especially in Malaysia.
Subgenotyping studies have only been conducted in India
[33,34,35] and very recently in Malaysia [12]. Therefore, the
aim of the present study was to further expand the previous study
by our group [12] in order to determine the diversity of
subgenotypes of Cryptosporidium isolated from hospitalized HIV
infected individuals from Malaysia in analyzing the polymor-
phisms at the gp60 locus.
Material and Methods
Sample collection
Fecal samples were collected from 346 HIV-infected individuals
from three different hospitals in Malaysia, namely: Hospital
Sungai Buloh, Selangor; University of Malaya Medical Centre,
Kuala Lumpur and Hospital Raja Zainab Perempuan II,
Kelantan. Ethical clearance from the Medical Ethics Committee
of University Malaya Medical Centre (IRB Ref. No. 655.17) and
Ministry of Health National Medical Research Register (MOH-
NMRR) (MOH-NMRR ID: # 09-286-3930) were obtained prior
to the commencement of the study.
Informed consent was obtained from each HIV-infected patient
who voluntarily participated after a clear explanation of the
research objectives. The inclusion criteria for participation were
HIV infected patients regardless of age, race, with or without
symptoms and patients who consented to the study, whereas the
exclusion criteria were those who were not HIV infected and who
did not give their consent to participate in the study. Clinical data
were obtained from patient’s medical record with patient’s consent
and permission from health authorities. Fecal samples were
preserved in 2.5% potassium dichromate solution and stored at
4uC for further analysis [36].
Clinical data were available only for 253 patients out of 346 (93
patients did not provide consent for their clinical records to be
accessed). In addition, of the 253 HIV patients whose clinical data
were available, there were 130 (51.4% of 253) patients who also
had opportunistic infections (OIs), whereas 123 (48.6%) did not
have OIs.
Extraction of Cryptosporidium genomic DNA
Purifying stool samples with immunomagnetic separa-
tion method. A total of 346 stool samples were used for
molecular characterization. The oocyst samples were purified by
IMS according to the manufacturer’s instructions in the Dynal
IMS Kit from Dynal GC-Combo kit (Dynal, cat. No. 730.02,
Oslo, Norway). Briefly, 10 ml of sample suspension was
transferred into tube which has been added with 1 ml of 106
SL buffer A and buffer B, then 100 ml of Dynabeads anti-
Cryptosporidium was added into the tube. The tube was affix to a
rotating mixer and was rotated at approximately 18 rpm for
1 hour at room temperature. The sample tube was removed from
the mixer and placed in the magnetic particle concentrator (MPC-
1). The sample was then rocked gently for 2 minutes, all
supernatant decanted from the tube. After that, the capture tube
was removed from MPC-1 and the sample was resuspended in
1m lo f1 6SL Buffer A. The mixture was then transferred into a
1.5 ml microcentrifuge tube. The microcentrifuge tube was placed
into the second magnetic particle concentrator (MPC-S) with
magnetic strip in place. The tube was gently rocked / rolled for
1 minute. Without removing the tube from MPC-S, the
supernatant was gently aspirated from the tube. The oocysts-
beads complex was then stored in 220uC.
DNA extraction
Genomic DNA was extracted from the IMS-isolated oocysts
using QIAgen DNA Mini kit (QIAGEN, cat. No. 51306,
Germany) according to manufacturer’s description. Briefly, IMS-
isolated oocysts were resuspended in lysis buffer and underwent 5
consecutive cycles of freezing in liquid nitrogen for 1 min and
thawing at 56uC for 2 min, with vortexing for 30 sec for every
cycle in order to rupture the Cryptosporidium oocysts. DNA was
eluted in 50 m l buffer (Qiagen) and stored at 220uC until further
use.
Amplification of DNA by nested-PCR targeting gp60
gene
Two step nested-PCR assays [26,37] were used to generate
amplicons for subgenotyping by sequencing a fragment of the
gp60 gene. In the first round of PCR, the gp60 gene (,980–
1000 bp) was amplified from DNA using a 21-mer forward primer
(gp15-ATG; 59-ATG AGA TTG TCG CTC ATT ATC-39) and a
21-mer reverse primer (gp15-STOP; 59-TTA CAA CAC GAA
TAA GGC TGC-39). Subsequently, a 450-bp fragment was
amplified in the secondary reaction using primers gp15-15A (59-
GCC GTT CCA CTC AGA GGA AC -39) and gp15-15E (59-
CCA CAT TAC AAA TGA AGT GCC GC -39). The primary
Subgenotypes in HIV/AIDS Individuals
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consisted of premixed reagents containing 200 mM of each of the
four deoxynucleoside triphosphates (dNTP) (Fermantas, cat.
No. #R0192, Ontario, Canada), 4 mM of each of primers gp15-
ATG/ gp15-STOP and gp15-15A/ gp15-15E (Bio-Basic, Cana-
da), 3 mM MgCl2 (Fermentas, cat.no. # R0971, Ontario,
Canada), 2.5 U Taq polymerase (New England Biolabs, cat.
No. M0267L, Ipswich, USA), and 16 ThermoPol PCR buffer
(New England Biolabs, cat. No. M0267L, Ipswich, USA). Two ml
of DNA template was used in the primary PCR whereas 5 mlo f
the first PCR product was used as template in the secondary PCR.
The secondary PCR reagent concentrations were similar to the
primary as mentioned above. The cycling condition was as follows;
hot start at 94uC for 5 min, followed by 40 cycles of denaturing for
30 sec at 94uC, annealing for 45 sec at 55uC and extension for
1 min at 72uC, followed by a final extension at 72uC for 10 min.
The secondary PCR had a 35 cycle conditions and the annealing
time and extension time in the secondary PCR was 30 sec instead
of 45 sec and 1 min, respectively. The PCR products were
resolved on 2% agarose gel and visualized with Sybr safe stain.
Purification of PCR product
The PCR product was purified using QIAquick PCR
purification kit (QIAgen, cat. No. 28104, Germany) according to
the manufacturer’s protocol. The volume of elution buffer added
to the column was 30 ml to increase the concentration of the eluted
DNA.
DNA sequencing
For the Cryptosporidium isolates of gp60 gene, sequencing was
done in both directions using forward primer (gp15-15A; 59-GCC
GTT CCA CTC AGA GGA AC -39) and reverse primer (gp15-
15E; 59-CCA CAT TAC AAA TGA AGT GCC GC -39) [28].
DNA sequencing was carried out by Medigene (SOLGENT CO.
LTD, Korea).
Sequence analysis and phylogenetic analysis
Nucleotide sequences for all 18 gp60 subgenotypes were
obtained directly from the nested PCR amplicons and sequenced
in forward and reverse directions. All 18 pairs of sequences were
edited via Applied Biosystems Sequence Scanner software v1.0
Sequence Trace Viewer and Editor (www. en.bio-soft.net/dna/ss).
Edited sequences were aligned and consensus sequences were
created for each isolates using the BioEdit (www.mbio.ncsu.edu)
programme. Each consensus sequence was used for the identifi-
cation of Cryptosporidium gp60 genotypes and sequences were
searched using basic local alignment search tool (BLAST) (www.
ncbi.nlm.nih.gov/blast) in order to get the 100% similarity with
the gp60 genotypes sequences deposited in the GenBank and
published in peer-reviewed international scientific journals. Gp60
sequences were compared with reference sequences of C. parvum
and C. hominis families. Isolates of C. parvum genotypes IIa
(HQ631411, HQ631412, HQ631413, HQ631414, HQ631415,
HQ631416, HQ631417, HQ631418, HQ631419, HQ631420,
HQ631421 and HQ631422) and C. parvum genotypes IId
(HQ631423) sequences together with other C. parvum genotypes
families reference sequences (i.e., IIa, IIb, IIc, IId, IIe, IIf, IIg, IIh,
IIi, IIj and IIk) together with C. hominis (AY738187) [24] as
outgroup were aligned via the program Clustal W [38]. Multiple
sequence alignment of the representative Cryptosporidium isolates
and reference sequences of C. parvum were conducted using the
program BioEdit [39]. Whereas, isolates of C. hominis genotypes Ia
(HQ631406, HQ631407 and HQ631408), and C. hominis
genotypes Ib (HQ63109 and HQ631410) sequences collectively
with similar C. hominis genotypes families reference sequences (i.e.,
Ia, Ib, Id, Ie and If) together with C. parvum (EU164809) [40] as
outgroup were aligned via the program Clustal W [38] and
multiple sequence alignment were generated by using the BioEdit
programme [39].
The phylogenetic analysis of the gp60 gene nucleotide sequence
data were conducted via Bayesian Inference using the software
package MrBayes v3.1.2 (http://mrbayes.csit.fsu.edu/index.php).
Upon the completion of the Bayesian analysis, a 50% majority-
rule consensus tree for each species and genotypes were
constructed in Treeview X v.0.5. (http://darwin.zoology.gla.ac.
uk/_rpage/treeviewx/). The percentage of replicate trees in which
the associated taxa clustered together in the bootstrap test values
(1.00) is shown next to the branches.
Microsatellite analysis of Cryptosporidium gp60
subgenotypes isolated from HIV patient
All the 18 gp60 Cryptosporidium sequences were analyzed for
‘‘TCA’’ microsatellite region. Gp60 subgenotype results analysis
display high mutation rates, in particular, a ‘‘hyper-variable’’
microsatellite region. The gp60 subgenotype ‘‘TCA’’ microsatellite
region, showed triplet codons were categorized according to the
number of trinucleotide repeats coding for the amino acid serine.
Cryptosporidium gp60 subgenotypes consist of a variable number of
‘‘A’’ (TCA), ‘‘G’’ (TCG), ‘‘T’’ (TCT) and ‘‘R’’ (ACATCA)
[40,41,42].
Nucleotide sequence accession number
Data on the nucleotide sequences of the gp60 gene of C. parvum
genotypes have been deposited in GenBank under the accession
numbers HQ631411 to HQ631423 representing isolates of C.
parvum genotypes IIa and IId respectively. Whereas, C. hominis have
been deposited in GenBank under the accession numbers
HQ631406 to HQ631410 representing isolates of C. hominis
genotypes Ia and Ib. C. parvum genotype IIa accession number
HQ631423 and C. hominis genotype Ia and Ib with accession
numbers HQ631406, HQ631408, HQ631409 and HQ631410
have also been reported in another publication by our group [12].
Results
Analysis of Cryptosporidium via nested-PCR targeting 60 kDa
glycoprotein (gp60) gene resulted in a distinct band at 450 bp
(Figure 1). Eighteen (5.2% of 346) isolates were determined as
Cryptosporidium positive with 72.2% (of 18) identified as C. parvum
whilst 27.7% as C. hominis. Of these 18 Cryptosporidium infected HIV
patients, personal and clinical information were also obtained.
Most patients infected with Cryptosporidium were male (88.8%, 16 of
18), .35 years of age (mean age 38.6 yrs, 55.5%), asymptomatic
(94.4%) and had a CD4 count of ,200/mm
3 (55.5%). There were
two patients (11.1%) who had CD4 counts .200 cells/mm
3 while
six (33.3%) patient’s CD4 counts were not available from their
clinical records.
BLAST results of the gp60 positive samples showed that HIV
patients harboured four Cryptosporidium genotypes, 13 (72.2%) were
identified as C. parvum genotypes IIa and IId and 5 (27.7%) were C.
hominis genotypes Ia and Ib (Table 1).
Phylogenetic analysis of sequence data of gp60 C. parvum
genotypes IIa and IId isolates of HIV patients were conducted by
Bayesian Interferance (BI) (Figure 2). The relationship of gp60
genotypes of Cryptosporidium isolates and reference sequences of C.
parvum genotypes recognized the presence of genotypes IIa and IId
in HIV patients. Cryptosporidium isolates of C. parvum genotypes IIa
(HQ631411, HQ631412, HQ631413, HQ631414, HQ631415,
Subgenotypes in HIV/AIDS Individuals
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HQ631421 and HQ631422) were clustered with reference
sequence of C. parvum genotypes IIa (A14G2R1, A17G1R1,
A19G3R1, A20G3R1, A22G3R1 and A23G3R1) with high
internode value (i.e., 0.93). Whilst isolate of C. parvum genotypes
IId (HQ631423) was grouped with reference sequences of C.
parvum genotypes IId (A17G2R1, A18G2R1, A19G2R1,
A21G2R1, A22G2R1) with highest internode value (i.e., 1.00).
Analysis of the gp60 C. hominis genotypes Ia and Ib isolates of HIV
patients were built by means of Bayesian Interferance (BI)
(Figure 3). The association of gp60 genotypes of Cryptosporidium
isolates and reference sequences of gp60 C. hominis genotypes
predicted the presence of genotypes Ia and Ib in this study.
Cryptosporidium isolates of C. hominis genotypes Ia (HQ631406,
HQ631407 and HQ631408) were grouped with reference
sequences of C. hominis genotype Ia (A12G1, A12G1R1, A14R1,
A15R1, A19R1, A21R1, A22R1, A23R1, A23R2, A24R1 and
A27R1) with high internode value (i.e., 1.00). Furthermore,
isolates of C. hominis genotype Ib (HQ631409 and HQ631410)
were clustered with reference sequences of C. hominis genotype Ib
(A9G3R2, A18G1R4, A23G2R2) with 0.88 internode value.
Microsatellite analysis revealed that in the present study, C.
parvum gp60 genotype found in HIV patients comprised of
genotypes IIa and IId. C. parvum genotype IIa included two
isolates of subgenotypes IIaA13G1R1 and IIaA13G2R1 each,
three isolates of IIaA14G2R1 and five isolates of IIaA15G2R1.
Whilst C. parvum IId consisted of a single isolate of subgenotype
IIdA15G1R1. The present results disclosed that the majority of C.
parvum IIaA15G2R1were male, Malay, IVDU having CD4 cells
count ,200 cells/mm
3 (Table 2). These patients had co-infection
with OIs such as Mycobacterium tuberculosis infections, toxoplasmosis,
candidiasis, salmonellosis, cryptococcosis and histoplasmosis.
Interestingly, a Chinese male, IVDU patient with subgenotype
IIaA15G1R1 had CD4 cells count .200 cells/mm
3 (i.e., 320
cells/mm
3).
Subsequently, C. hominis genotypes Ia and Ib encode the
microsatellite triplet codons based on the integer of trinucleotide
repeats. Subgenotype exploration showed that isolates of gp60 C.
hominis genotype Ia were determined as two isolates of subgeno-
types IaA14R1 and single isolate of subgenotypes IaA18R1
whereas, further analysis of C. hominis Ib indicated two isolates of
subgenotype IbA10G2R2 (Table 1). Subgenotype IaA14R1 was
identified in a heterosexual, Chinese male having CD4 counts
,50 cells/ mm
3 (Table 2). Other co-infections included Herpes
simples and Kaposi’s sarcoma. Whilst subgenotype IaA18R1 was
found in a Malay IVDU who did not have any other opportunistic
infection. However, C. hominis subgenotype IbA10G2R2 was
discovered in two patients. One was an Indian IVDU with CD4
counts ,50 cells/ mm
3 and having OIs such as Mycobacterium
tuberculosis infection and salmonellosis. Whilst the other was a
female Burmese heterosexual with CD4 counts .200 cells/ mm
3
and experiencing co-infection with cryptococcosis (Table 2).
Discussion
In this study, using nested-PCR technique targeting the gp60
gene, it was discovered that 5.2% (18 of 346) of sampled Malaysian
HIV individuals were infected with Cryptosporidium. BLAST
analysis of these 18 sequences which was confirmed by
phylogenetic analysis showed that 13 (72.2%) were of C. parvum
genotype and 5 (27.7%) of C. hominis genotype. The C. parvum gp60
genotype found in these HIV patients comprised of genotypes IIa
and IId. Within the C. parvum genotype IIa family, all sequences
were identical in the non-repeat region (i.e. had one copy of
sequence ACATCA immediately after the trinucleotide repeats),
while the trinucleotide repeat region contained one and two copies
of the TCG repeat and 13, 14 and 15 copies of TCA. C. parvum
genotype IIa included 2 isolates of subgenotypes IIaA13G1R1 and
IIaA13G2R1 respectively, 3 isolates of subgenotype IIaA14G2R1
and 5 isolates of subgenotype IIaA15G2R1. C. parvum gp60
subgenotype IIaA15G2R1 is the most common subgenotype
detected in this study. C. parvum IId subgenotype consisted of a
Figure 1. Representative presentation of PCR products gener-
ated from Cryptosporidium gp60 gene from fecal specimens on
2% agarose electrophoretic gel. M: 100-bp DNA marker, with
molecular size indicated in base-pair unit for prominent band. NC:
Negative control/DNA blank (PCR mixture plus the product of the first
negative control which was used in the primary PCR as template). PC:
Positive control (Cryptosporidium parvum H3 isolate). Lanes 1–6:
Secondary PCR product from Cryptosporidium positive specimens.
doi:10.1371/journal.pone.0031139.g001
Table 1. Cryptosporidium subgenotypes and microsatellite analysis of gp60 gene in HIV patients (n=18).
Species No. of Patients Genotypes Subgenotypes No. of Isolates
Cryptosporidium parvum 13 (72.2%) IIa A13G1R1 2
A13G2R1 2
A14G2R1 3
A15G2R1 5
IId A15G1R1 1
Cryptosporidium hominis 5 (27.7%) Ia A14R1 2
A18R1 1
Ib A10G2R2 2
doi:10.1371/journal.pone.0031139.t001
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diversity compared to previous results by our group, whereby in
that study only subgenotype C. parvum IIdA15G2R1 was found
[12].
Human infections with C. parvum genotype family IIa are
commonly seen in areas with intensive animal production, such as
the UK, Portugal, Slovenia, southeastern Australia and rural areas
of the North America [28,43–47]. This is partially due to relative
high occurrence of zoonotic infections in these areas because cattle
and sheep are commonly infected with C. parvum of the genotype
family IIa, and some of the genotypes within the family have been
found in both humans and animals in the same area [44,45].
In contrast, C. parvum genotype IIa has been rarely found in
humans in developing countries or cities in North America
[32,44,48]. In the present study, C. parvum IIaA15G2R1 was found
to be the most common subgenotype in the Malaysian HIV
patients and this subgenotype has previously been widely reported
from humans, calves and outbreaks linked to farms from various
Figure 2. Phylogenetic analysis of gp60 sequence data representing Cryptosporidium parvum from HIV patients using Bayesian
inference (BI). Sequences from the present study as well as reference sequences representing C. parvum subtypes (acquired from GenBank) are
indicated. Posterior probabilities are indicated at all major nodes. C. parvum genotype IIa accession number HQ631423 have been reported in
another publication by our group [12].
doi:10.1371/journal.pone.0031139.g002
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suggesting that the transmission of C. parvum IIa among Malaysian
HIV patients may be potentially zoonotic in nature.
Besides genotype IIa, C. parvum subgenotype IId (IIdA15G1R1)
was also identified in the Malaysian HIV individuals. Genotype
IId has been found in humans, AIDS patients and in cattle
[25,28]. Similarly, C. parvum genotype IId was commonly seen in
Kuwaiti children [24]. Despite the high occurrence of IId in AIDS
patients in Lisbon, IId infections in animals were only seen in the
municipality of Odemira in southern Portugal [49]. As far as we
know, four IId subgenotype have been recorded in both humans
and non-human hosts; these are C. parvum IIdA17G2R1 [49,54],
IIdA19G2R1 [49,55], IIdA22G2R1 [28,55] (from humans and
cattle) and IIdA18G2R1 [50,56] (humans and goats), thus
indicating that subgenotype IIdA15G1R1 found in the present
study as the first subgenotype ever reported.
Presently, C. hominis comprises six defined gp60 subgenotype
families (Ia–Ig; excluding Ic, which is yet undefined). The
multiplicity of C. hominis subgenotype of the present study showed
5 (14%) of the 18 HIV-infected isolates being designated into two
different genotypes (i.e., Ia and Ib). Microsatellite analysis
indicated that isolates of gp60 C. hominis genotype Ia were
determined as subgenotypes IaA14R1 in 2 isolates and IaA18R1
in 1 isolate whereas, further analysis of C. hominis genotype Ib
indicated IbA10G2R2 subgenotype in two Malaysian HIV
patients.
C. hominis tends to be responsible for most of human
cryptosporidiosis in many regions of the world [57]. The
distribution of gp60 subgenotype families in the world indicates
the existence of population substructure in C. hominis [49]. C.
hominis genotype Ib is a dominant and broadly distributed
genotype whereas genotype Ia, Id and Ie are found less frequently
as compared to genotype Ib [25]. C. hominis infections in AIDS
patients from Portuguese indicated that two thirds of C. hominis
parasites found in HIV-seropositive patients were of subgenotype
IbA10G2 [49]. This strongly supported the results of the current
study in which C. hominis IbA10G2R2 was found in the present
studied HIV patients. Cryptosporidium hominis IbA10G2R2 has been
identified also as the dominant subtype among isolates from
humans infected during two waterborne outbreaks in Northern
Ireland [43] and, more recently, a waterborne outbreak in France
[58]. On the other hand, IbA10G2R2 is the only C. hominis gp60
subtype indicated to have the potential to infect non-humans (i.e.
reported in a three-days suckler calf and a six-year old Aberdeen
Angus-cross cow [59]), suggesting possible zoonotic transmission.
Based on its dominance in humans and its association with
waterborne outbreaks and transmission from animal to humans, it
is proposed that IbA10G2R2 merits attention as the most
significant C. hominis gp60 subgenotype linked to human
cryptosporidiosis globally with zoonotic potential [25].
It is interesting to note that genotypes Ia and Id were less
commonly found genotypes in humans. Within genotype family
Ia, subgenotype IaA12G1R1 has been isolated from human in
Japan [60], Nepal [50], Pakistan [46] and Peru [21] whilst another
subgenotype IaA21G1R1, has been reported from Egypt, India,
Malawi, South Africa and Spain [30,32,61]. The results of the
present study showed that C. hominis infection among HIV patients
was caused by C. hominis subgenotypes IaA14R1 and IaA18R1. To
the best of our knowledge subgenotype IaA18R1 have not been
reported previously. Lim et al. [12] reported high diversity of C.
hominis subgenotypes in HIV individuals, not only IaA14R1 and
IbA10G2R2 were detected, but also IdA15R2, IeA11G2T3R1
and IfA11G1R2.
Figure 3. Phylogenetic analysis of gp60 sequence data
representing Cryptosporidium hominis from HIV patients using
Bayesian inference (BI). Sequence from the present study as well as
reference sequences representing C. hominis subtypes (acquired from
GenBank) are indicated. Posterior probabilities are indicated at all major
nodes. C. hominis genotype Ia accession numbers HQ631406 and
HQ631408 and genotype Ib accession numbers HQ631409 and
HQ631410 have been reported in another publication by our group
[12].
doi:10.1371/journal.pone.0031139.g003
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variation of gp60 subgenotypes in human and animals [25] but the
clinical and epidemiological significance of various Cryptosporidium
species and subgenotypes in humans are not fully understood yet.
However, Cama et al. [62] reported that in AIDS patients in Lima,
Peru, infections with C. canis, C. felis, and subgenotype family Id of
C. hominis were significantly associated with diarrhea, whereas
infections with C. parvum were significantly associated with chronic
diarrhea and vomiting. It was also noted that infections with C.
hominis Ib subgenotype family were marginally associated with
diarrhea and vomiting. In contrast, infections with C. meleagridis
and Ia and Ie subgenotype families of C. hominis were usually
asymptomatic [62]. Unfortunately, none of the studies showed the
clinical correlation of genotypes and subgenotypes.
The clinical manifestation for Malaysian HIV patients appears
to be in contrast with those of Peruvian patients, where infections
with C. parvum and C. hominis subgenotypes were not associated
with chronic diarrhea and vomiting. These results demonstrated
that different Cryptosporidium genotypes and subgenotype families
may be linked to different clinical manifestations. Indeed, further
detailed investigations are warranted in order to improve
understanding of these associations. The occurrence of distinctive
multilocus subgenotypes in both C. hominis and C. parvum
populations in Malaysia that can be differentiated from other
geographic regions, including the nearby Southeast Asian
countries, is notable and requires further investigations. The fact
that C. hominis from different areas may have an identical gp60
subgenotype but a different microsatellite subtype is also
noteworthy, as some C. hominis subgenotypes, such as IbA10G2R2,
are commonly associated with water-borne outbreaks in industri-
alized countries. The distinction is important in mapping the
transmission of the parasite, especially where tracking infection
pathways is necessary, such as in the investigations of environ-
mental and zoonotic transmission.
In conclusion, this study documented the distribution of
cryptosporidial species and subgenotypes in HIV infected
individuals in Malaysia. Gp60 genotype analysis showed HIV-
patients were infected with C. parvum IIa and IId genotypes and C.
hominis Ia and Ib genotypes denoting the possibility of zoonotic as
well as anthroponotic transmissions of cryptosporidiosis in these
individuals. A comprehensive study analysing clinical manifesta-
tions of the gp60 subgenotypes in relation to the distinct
microsatellites from different areas need to be studied further.
This would promote greater understanding of Cryptosporidium
epidemiology and various pathogenicities.
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Table 2. Clinical data on Cryptosporidium infected HIV patients and the genetic analysis of gp60 gene.
Sample no.
Age
(yrs.) Sex
a
Ethinc
race
b
CD4 count
(10
3/ml)
Mode of
transmission
c Species
Genotype
pgp60 Subgenotype
Opportunistic
infections ( OIs)
1 31 M M 6 IVDU C. parvum IIa A13G1R1 Histoplasmosis,
Salmonella septicemia
2 46 M M 3 IVDU C. parvum IIa A14G2R1 Cerebral Toxoplasmosis
3 31 M M 34 Unknown C. parvum IIa A15G2R1 Cerebral Toxoplasmosis
4 51 M C 320 IVDU C. parvum IIa A15G2R1 No OIs
5 36 M C 2 IVDU C. parvum IIa A15G2R1 Candidiasis
6 38 M M 27 IVDU C. parvum IIa A15G2R1 Mycobacterium
tuberculosis
7 41 M M 75 Heterosexual C. parvum IIa A13G2R1 Cryptococcosis
8 42 M M 59 IVDU C. parvum IIa A13G2R1 No OIs
91 3 M M N A N A C. parvum IIa A14G2R1 NA
10 1 F M NA NA C. parvum IIa A14G2R1 NA
11 47 M I NA IVDU C. parvum IIa A15G2R1 NA
12 32 M M NA NA C. parvum IIa A13G1R1 NA
13 39 F I NA NA C. parvum IId A15G1R1 NA
14 46 M C 10 Heterosexual C. hominis Ia A14R1 Herpes simplex, Kaposi’s
sarcoma
15 22 M M 38 IVDU C. hominis Ia A18R1 No OIs
16 35 M C NA NA C. hominis Ia A14R1 NA
17 24 M F 256 Heterosexual C. hominis Ib A10G2R2 Cryptococcosis
18 42 M C 2 IVDU C. hominis Ib A10G2R2 Mycobacterium
tuberculosis, Salmonella
septicemia
a: M=male, F=female.
b: M=Malay, C=Chinese, I=Indian, F=Foreigner (Burmese),
c: IVDU=Interavenous drug users,
NA: Data not available.
doi:10.1371/journal.pone.0031139.t002
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